Measuring the cost-effectiveness of lipid-lowering drugs in the elderly:: the outcomes research and economic analysis components of the PROSPER trial - Avorn, Jerry; Benner, Josh; Ford, Ian; Ganz, David A; Gaw, Allan; Glynn, Robert J; Jackson, Joseph; Lagaay, A.Margot; Schneeweiss, Sebastian; Walley, Thomas; Wang, Philip S (Controlled clinical trials, 2002)
Keywords: Aged; Aged, 80 and over; Anticholesteremic Agents - economics; Anticholesteremic Agents - therapeutic use; Biological and medical sciences; Cardiovascular Diseases - prevention & control; Cost-Benefit Analysis - statistics & numerical data; Cost-effectiveness analysis; Direct Service Costs; Elderly; Female; General and cellular metabolism. Vitamins; Humans; Ireland; Life Tables; Male; Markov Chains; Medical sciences; Methods; Multicenter Studies as Topic; Netherlands; Pharmacology. Drug treatments; Pravastatin; Pravastatin - economics; Pravastatin - therapeutic use; Quality-Adjusted Life Years; Randomized controlled trial; Randomized Controlled Trials as Topic - methods; Randomized Controlled Trials as Topic - statistics & numerical data; Risk; Scotland; Software Design; Scotland; Netherlands; Ireland; Cost-effectiveness analysis; Pravastatin; Randomized controlled trial; Elderly; Methods; Human; Costs; Methodology; Enzyme; Enzyme inhibitor; Metabolic diseases; Lipids; Hyperlipoproteinemia; Statin derivative; Chemotherapy; Treatment; Health economy; Clinical trial; Hydroxymethylglutaryl-CoA reductase; Oxidoreductases; Dyslipemia; Cost efficiency analysis; Antilipemic agent